ANTONIOLI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 9.727
EU - Europa 4.870
AS - Asia 1.369
AF - Africa 231
SA - Sud America 21
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.234
Nazione #
US - Stati Uniti d'America 9.516
IT - Italia 1.998
SE - Svezia 825
CN - Cina 612
BG - Bulgaria 442
AT - Austria 438
DE - Germania 336
GB - Regno Unito 251
VN - Vietnam 227
CA - Canada 196
CI - Costa d'Avorio 151
TR - Turchia 140
SG - Singapore 132
BE - Belgio 108
FI - Finlandia 102
UA - Ucraina 101
HK - Hong Kong 98
RU - Federazione Russa 89
IN - India 76
FR - Francia 50
SN - Senegal 46
PL - Polonia 43
CH - Svizzera 36
IR - Iran 24
NG - Nigeria 22
NL - Olanda 15
JP - Giappone 14
MX - Messico 13
BR - Brasile 11
KR - Corea 11
PK - Pakistan 11
AU - Australia 9
ES - Italia 8
CL - Cile 5
NO - Norvegia 5
EC - Ecuador 4
ID - Indonesia 4
IE - Irlanda 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
UZ - Uzbekistan 4
EU - Europa 3
GH - Ghana 3
HU - Ungheria 3
LB - Libano 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
IL - Israele 2
MA - Marocco 2
MO - Macao, regione amministrativa speciale della Cina 2
PH - Filippine 2
RS - Serbia 2
UG - Uganda 2
BD - Bangladesh 1
BJ - Benin 1
CM - Camerun 1
CO - Colombia 1
CU - Cuba 1
DZ - Algeria 1
IQ - Iraq 1
LI - Liechtenstein 1
LV - Lettonia 1
MK - Macedonia 1
PA - Panama 1
TH - Thailandia 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 16.234
Città #
Fairfield 1.263
Woodbridge 1.175
Ann Arbor 940
Houston 827
Chandler 802
Ashburn 633
Seattle 499
Wilmington 478
Cambridge 448
Sofia 442
Milan 422
Serra 376
Vienna 303
New York 273
Beijing 264
Princeton 193
Ottawa 183
Lawrence 171
Abidjan 151
Medford 151
Izmir 129
Pisa 122
Jacksonville 118
Dong Ket 116
Florence 110
Des Moines 107
Brussels 106
Nanjing 93
Hong Kong 86
Bremen 83
Dearborn 73
London 67
Rome 65
Nanchang 47
Dakar 46
Lancaster 44
Redwood City 40
San Diego 40
Falls Church 39
Frankfurt am Main 38
Boulder 29
Washington 29
Bern 28
Pune 26
Warsaw 25
Hebei 22
Lagos 22
Marseille 22
Changsha 20
Jüchen 19
Kunming 19
Norwalk 19
Tianjin 19
Bologna 17
Boardman 16
Jiaxing 16
Livorno 16
Detroit 15
Pistoia 15
Guangzhou 14
Palermo 14
Phoenix 14
Shenyang 14
Auburn Hills 13
Hefei 12
Lucca 11
Singapore 11
Turin 11
Nürnberg 10
Padova 10
Parma 9
Shanghai 9
Ancona 8
Chicago 8
Hangzhou 8
Omaha 8
Redmond 8
Toronto 8
Aguascalientes 7
Council Bluffs 7
Fremont 7
Los Angeles 7
Montecatini Terme 7
Tappahannock 7
Dallas 6
Molise 6
Bari 5
Bergen 5
Cagliari 5
Central District 5
Chengdu 5
Columbus 5
Helsinki 5
Naples 5
Santiago 5
Tagliacozzo 5
Ballabio 4
Busto Arsizio 4
Capannori 4
Chiswick 4
Totale 12.277
Nome #
Derivati isoindolici come attivatori di AMPK 380
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 191
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. 182
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 176
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 166
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 160
Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations 154
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 154
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 149
Preparation of isoindoline derivatives for use as AMPK activators 148
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 145
Derivati benzofuranici come attivatori di AMPK 144
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 141
Enteric protective effects of the combination Bifidobacterium longum and lactoferrin in a rat model of diclofenac-induced intestinal injury. 140
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 139
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district 136
Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon 136
Adenosine and inflammation: what's new on the horizon? 135
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic 135
Anti-CD73 in cancer immunotherapy: awakening new opportunities 133
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 132
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 131
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 130
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation 129
CD39 and CD73 in immunity and inflammation 129
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 125
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 124
Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular disease 124
Expression pattern of COX isoforms in experimental models of enteric and airway inflammation 122
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 121
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 120
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors 120
Allopurinol adherence among patients with gout: an Italian general practice database study 120
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection 120
Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation 120
Role of Cyclooxygenase isoforms in the neuromodulation of colonic motility in Humans and Mice 119
Cyclooxygenase expression in neuromuscular compartment of normal and inflamed colon 118
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 118
Transient acute liver failure complicating transurethral resection syndrome 118
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies 118
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders 117
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 117
Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage 116
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction 116
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 116
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 116
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review 114
A1 and A2a receptors mediate inhibitory rffects of adenosine on the motor activity of human colon 114
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 114
Telogen effluvium following bivalent human papilloma virus vaccine administration: a report of two cases 113
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 113
Control of enteric neuromuscular functions by purinergic A3 receptors in normal rat distal colon and experimental bowel inflammation 111
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases 110
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 110
Neuromodulation of colonic motility by cycloxygenase isoforms in the presence of experimental bowel inflammation 109
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway 109
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 109
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 109
Role of A2a adenosine in the regulation of colonic motility in normal human colon 106
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 106
Adenosine pathway and cancer: where do we go from here? 106
Adenosine regulation of the immune system 106
Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing 105
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 105
A holistic view of adenosine pathways in the control of intestinal neuromuscular functions: the enteric purinome concept 103
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon 103
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models 103
Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis 102
Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease 102
AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases 102
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects 102
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 101
High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse 101
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 101
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 100
Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of iNOS and oxidative stress 99
Differential role of A1 and A2a purinergic receptors in the control of colonic neurumuscular function in the presence of experimental colitis 98
Reduced modulating actions of adenosine pathways on enteric neuromuscular activity in experimental colitis 97
Cyclooxygenase inhibitors modulate pro-fibrotic signalling mediated by TGFbeta in experimental colitis 97
Drug-induced taste and smell alterations: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting 97
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 96
Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients 95
Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? 94
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 94
null 94
Functional Neuroplasticity in Acute Diverticulitis: Differential Regulation of Colonic Excitatory Nerve Pathways By Cyclooxygenase Isoforms 93
Risankizumab for the treatment of moderate to severe psoriasis 93
Preparation of benzofuran derivatives for use as AMPK activators 93
Immunity, inflammation and cancer: a leading role for adenosine 91
Inflammation and Vascular Ageing: From Telomeres to Novel Emerging Mechanisms 91
Inhibition of adenosine deaminase attenuates inflammation in experimental colitis 90
Effects of a bicarbonate-alkaline mineral water on digestive motility in experimental models of functional and inflammatory gastrointestinal disorders 90
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 90
Pharmacological modulation of adenosine receptor pathways and inflammatory disorders: the way towards novel therapeutics? 89
Adenosine Metabolism, Immunity and Joint Health 89
Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice 89
Effects of pantoprazole on ulcer healing delay associated with NSAID treatment 89
Resistance Artery Mechanics and Composition in Angiotensin II-Infused Mice: Effects of Cyclooxygenase-1 Inhibition 88
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment 88
Dietary flavonoids as a potential intervention to improve redox balance in obesity and related co-morbidities: a review 88
Totale 11.801
Categoria #
all - tutte 42.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.163


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.123 0 0 0 0 0 0 0 63 28 311 397 324
2019/20203.240 347 245 188 233 329 346 335 298 351 209 286 73
2020/20211.713 142 118 118 90 123 81 66 127 229 201 106 312
2021/20222.064 37 87 66 105 390 307 74 115 127 91 138 527
2022/20233.227 347 411 227 290 293 399 79 267 513 79 247 75
2023/20242.089 279 280 316 216 377 434 68 119 0 0 0 0
Totale 16.885